Neoprofen patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
US8415337 RECORDATI RARE Ibuprofen compositions and methods of making same
Mar, 2032

(8 years from now)

Neoprofen is owned by Recordati Rare.

Neoprofen contains Ibuprofen Lysine.

Neoprofen has a total of 1 drug patent out of which 0 drug patents have expired.

Neoprofen was authorised for market use on 13 April, 2006.

Neoprofen is available in injectable;intravenous dosage forms.

The generics of Neoprofen are possible to be released after 02 March, 2032.

Drugs and Companies using IBUPROFEN LYSINE ingredient

Market Authorisation Date: 13 April, 2006

Treatment: NA


How can I launch a generic of NEOPROFEN before it's drug patent expiration?
More Information on Dosage

NEOPROFEN family patents

Family Patents

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic